Male breast cancer remains a rare but under-recognized condition in clinical practice, and delayed diagnosis continues to push most patients into advanced stages at presentation, according to a recent study published in the Journal of the Association of Physicians of India. In a retrospective analysis from ESIC Medical College and Hospital, clinicians reviewed 15 cases of male breast cancer managed between 2019 and 2025, with a mean patient age of 60 years. Despite its low incidence, the findings highlight a persistent gap in early recognition that may be limiting treatment outcomes.
Advanced Disease at First Presentation The study found that most patients presented late, with a median delay of six months from symptom onset to diagnosis. At the time of evaluation, 60% were in Stage III and 26.7% were already in Stage IV. All patients presented with a retroareolar mass, often accompanied…
